Sepsis Alliance AMR Conference 2023

Sepsis Alliance’s 2023 publication, The Healthcare C-Suite AMR Market Report found that only 26% of U.S. healthcare leaders grade themselves an ‘A’ on their hospital or health system’s antimicrobial resistance (AMR) efforts. The Sepsis Alliance AMR Conference aims to provide the tools and knowledge to improve these AMR efforts.

Sepsis and the emergence of antimicrobial resistance (AMR) are intricately intertwined and pose significant challenges. Primary reliance on broad-spectrum antimicrobials is often the initial approach in sepsis treatment, yet, curbing unnecessary antimicrobial use is imperative in combating the escalating threat of AMR.

As AMR intensifies, the likelihood of infections progressing to sepsis increases, rendering sepsis cases progressively more resistant to treatment and consequently subjecting patients to adverse outcomes such as amputations and fatalities. Effectively managing this intricate clinical interplay, addressing the global AMR threat, and enhancing future outcomes necessitate collaborative efforts across sectors, ongoing innovation, and educational initiatives.

Opportunities for AMR education for clinicians, caregivers, patients, and the public are viewed by 77% of healthcare executives as necessary for combating AMR. Participation in the Sepsis Alliance AMR Conference offers a unique opportunity for attendees to explore innovative ideas, gain inspiration, and learn about practical technologies to manage sepsis and counteract the expanding challenge of antimicrobial resistance.

Topics covered will include:

• A One Health approach to combating AMR;
• Maternal and pediatric AMR;
• AMR in ambulatory and outpatient settings;
• The role of Sepsis Teams in AMS.

• Explain the intricate link between sepsis and antimicrobial resistance;
• Identify tools and resources to champion responsible antimicrobial prescribing practices;
• Describe the pivotal role of healthcare executives and leadership in prioritizing, endorsing, and advancing stewardship efforts addressing antimicrobial resistance and sepsis;
• Restate methods for leadership to actively pursue inventive approaches that engage healthcare providers in initiatives aimed at tackling antimicrobial resistance and enhancing sepsis management.